Home › Compare › DPAT vs JNJ

DPAT vs JNJ: Dividend Comparison 2026

DPAT yields 4444.44% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DPAT wins by $19857738408180.46M in total portfolio value
10 years
DPAT
DPAT
● Live price
4444.44%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19857738408180.48M
Annual income
$19,016,069,933,146,186,000.00
Full DPAT calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DPAT vs JNJ

📍 DPAT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDPATJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DPAT + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DPAT pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DPAT
Annual income on $10K today (after 15% tax)
$377,777.78/yr
After 10yr DRIP, annual income (after tax)
$16,163,659,443,174,257,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DPAT beats the other by $16,163,659,443,174,257,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DPAT + JNJ for your $10,000?

DPAT: 50%JNJ: 50%
100% JNJ50/50100% DPAT
Portfolio after 10yr
$9928869204090.25M
Annual income
$9,508,034,966,573,093,000.00/yr
Blended yield
95.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DPAT
No analyst data
Altman Z
-12.1
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DPAT buys
0
JNJ buys
0
No recent congressional trades found for DPAT or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDPATJNJ
Forward yield4444.44% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$19857738408180.48M ✓$20.0K
Annual income after 10y$19,016,069,933,146,186,000.00 ✓$827.78
Total dividends collected$19800558376185.16M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DPAT vs JNJ ($10,000, DRIP)

YearDPAT PortfolioDPAT Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$455,144$444,444.44$10,676$355.77+$444.5K → DPAT
2$19,392,277$18,905,272.87$11,407$389.39+$19.38M → DPAT
3$773,548,232$752,798,494.96$12,198$426.53+$773.54M → DPAT
4$28,891,953,466$28,064,256,857.57$13,056$467.62+$28891.94M → DPAT
5$1,010,538,077,568$979,623,687,360.21$13,987$513.12+$1010538.06M → DPAT
6$33,103,483,882,921$32,022,208,139,922.89$14,998$563.56+$33103483.87M → DPAT
7$1,015,787,352,937,823$980,366,625,183,097.90$16,098$619.52+$1015787352.92M → DPAT
8$29,201,617,438,828,424$28,114,724,971,184,950.00$17,295$681.69+$29201617438.81M → DPAT
9$786,606,051,433,916,900$755,360,320,774,370,600.00$18,599$750.82+$786606051433.90M → DPAT
10$19,857,738,408,180,478,000$19,016,069,933,146,186,000.00$20,022$827.78+$19857738408180.46M → DPAT

DPAT vs JNJ: Complete Analysis 2026

DPAT — Stock

Dental Patient Care America, Inc., through its subsidiaries, provides services to dentists and the dental industry. The company organizes dentists into a co-operative model of contractually networked dental practices, allowing member dentists to access various benefits, such as programs to purchase supplies, laboratory and operating services, insurance and employee benefits programs, opportunities for profit sharing, preferential business financing, and dental practice transition funding opportunities. It also offers various dental patient marketing programs, such as organization of member dentists into a network, which offers dental care plans to employers and groups. In addition, Dental Patient Care America, Inc. offers dental benefit plans. The company was founded in 1998 and is based in Salt Lake City, Utah.

Full DPAT Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DPAT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DPAT vs SCHDDPAT vs JEPIDPAT vs ODPAT vs KODPAT vs MAINDPAT vs ABBVDPAT vs MRKDPAT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.